Researchers
at Massachusetts General Hospital are studying whether it is helpful to add
disease-altering drugs such as those used to treat rheumatoid arthritis to
antibiotics first line to treat Lyme disease.
Side effects are of some concern.
A much safer and less expensive way to treat the secondary autoimmune
response of Lyme is low-dose immunotherapy (LDI).
No comments:
Post a Comment